Nanomedicine for Gene Delivery and Drug Repurposing in the Treatment of Muscular Dystrophies.
- DOI
- 10.3390/pharmaceutics13020278
- Published
- 2021 Feb 19
- Container
- Pharmaceutics
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/pharmaceutics13020278,
title = {Nanomedicine for Gene Delivery and Drug Repurposing in the Treatment of Muscular Dystrophies.},
author = {Andreana I and Repellin M and Carton F and Kryza D and Briançon S and Chazaud B and Mounier R and Arpicco S and Malatesta M and Stella B and Lollo G},
year = {2021},
journal = {Pharmaceutics},
doi = {10.3390/pharmaceutics13020278},
url = {https://doi.org/10.3390/pharmaceutics13020278}
}RIS
TY - JOUR TI - Nanomedicine for Gene Delivery and Drug Repurposing in the Treatment of Muscular Dystrophies. AU - Andreana I AU - Repellin M AU - Carton F AU - Kryza D AU - Briançon S AU - Chazaud B AU - Mounier R AU - Arpicco S AU - Malatesta M AU - Stella B AU - Lollo G PY - 2021 JO - Pharmaceutics DO - 10.3390/pharmaceutics13020278 UR - https://doi.org/10.3390/pharmaceutics13020278 ER -
APA
I, A., M, R., F, C., D, K., S, B., B, C., R, M., S, A., M, M., B, S., & G, L. (2021). Nanomedicine for Gene Delivery and Drug Repurposing in the Treatment of Muscular Dystrophies.. Pharmaceutics. https://doi.org/10.3390/pharmaceutics13020278
Source records
- pubmed · retrieved 2026-09-27T13:35:23.748Z